Click to copy
Click to copy
Related topics

Protagonist Therapeutics: 2Q Earnings Snapshot

August 7, 2019

NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Wednesday reported a loss of $29.2 million in its second quarter.

The Newark, California-based company said it had a loss of $1.18 per share.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.

Protagonist Therapeutics shares have climbed 44% since the beginning of the year. The stock has dropped 13% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX

All contents © copyright 2019 The Associated Press. All rights reserved.